Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
AIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro....
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2022-03-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://ies.ijo.cn/en_publish/2022/3/20220304.pdf |
_version_ | 1819349507606839296 |
---|---|
author | Hyemin Seong Joo Yeon Jeong Jinhyun Ryu Juyeong Park Yong-Seop Han Hyun-Kyung Cho Seong Jae Kim Jong Moon Park Sang Soo Kang Seong Wook Seo |
author_facet | Hyemin Seong Joo Yeon Jeong Jinhyun Ryu Juyeong Park Yong-Seop Han Hyun-Kyung Cho Seong Jae Kim Jong Moon Park Sang Soo Kang Seong Wook Seo |
author_sort | Hyemin Seong |
collection | DOAJ |
description | AIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro. Death of RGCs were confirmed by TUNEL assay. Protein expression was confirmed by Western blotting and immunohistochemistry. In addition, flow cytometric analysis was used to confirm the response in the cell unit to obtain more accurate data. RESULTS: ErbB2 expression and apoptosis in the ganglion cell layer (GCL) increased after I/R injury. Treatment of Res rescued I/R-induced ganglion cell death, downregulated apoptosis and ErbB2 protein expression in the retina. In subsequent in vitro models, Res affects apoptosis by regulating the phosphorylation and expression of mouse double minute 2 homolog (MDM2), along with those of ErbB2. These results suggest that Res reverses GCL-specific apoptosis via downregulation of ErbB2 in ischemic injury. CONCLUSION: In light of Res favorable properties, it should be evaluated in the treatment of RGC death and related retinal disease characterized by ErbB2 and MDM2 expression. Therefore, Res is appropriate therapeutic agent for treating ischemic injury-related eye diseases by targeting the expression of ErbB2 and MDM2. |
first_indexed | 2024-12-24T19:01:37Z |
format | Article |
id | doaj.art-2f0018cd21f64ed0a74436aa96638615 |
institution | Directory Open Access Journal |
issn | 2222-3959 2227-4898 |
language | English |
last_indexed | 2024-12-24T19:01:37Z |
publishDate | 2022-03-01 |
publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
record_format | Article |
series | International Journal of Ophthalmology |
spelling | doaj.art-2f0018cd21f64ed0a74436aa966386152022-12-21T16:43:11ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982022-03-0115339440010.18240/ijo.2022.03.0420220304Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2Hyemin Seong0Joo Yeon Jeong1Jinhyun Ryu2Juyeong Park3Yong-Seop Han4Hyun-Kyung Cho5Seong Jae Kim6Jong Moon Park7Sang Soo Kang8Seong Wook Seo9Seong Wook Seo. Department of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, 15 Jinju-daero 816 Beon-gil, Jinju, Gyeongnam 52727, Republic of Korea. stramast@naver.com; Sang Soo Kang. Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, 15 Jinju-daero 816 Beon-gil, Jinju, Gyeongnam 52727, Republic of Korea. kangss@gnu.ac.krDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Gyeongsang National University Changwon Hospital, Gyeongsang National University, College of Medicine, Changwon 51472, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaAIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro. Death of RGCs were confirmed by TUNEL assay. Protein expression was confirmed by Western blotting and immunohistochemistry. In addition, flow cytometric analysis was used to confirm the response in the cell unit to obtain more accurate data. RESULTS: ErbB2 expression and apoptosis in the ganglion cell layer (GCL) increased after I/R injury. Treatment of Res rescued I/R-induced ganglion cell death, downregulated apoptosis and ErbB2 protein expression in the retina. In subsequent in vitro models, Res affects apoptosis by regulating the phosphorylation and expression of mouse double minute 2 homolog (MDM2), along with those of ErbB2. These results suggest that Res reverses GCL-specific apoptosis via downregulation of ErbB2 in ischemic injury. CONCLUSION: In light of Res favorable properties, it should be evaluated in the treatment of RGC death and related retinal disease characterized by ErbB2 and MDM2 expression. Therefore, Res is appropriate therapeutic agent for treating ischemic injury-related eye diseases by targeting the expression of ErbB2 and MDM2.http://ies.ijo.cn/en_publish/2022/3/20220304.pdfischemia/reperfusion injuryhypoxiaretinal ganglion cellresveratrolerbb2 |
spellingShingle | Hyemin Seong Joo Yeon Jeong Jinhyun Ryu Juyeong Park Yong-Seop Han Hyun-Kyung Cho Seong Jae Kim Jong Moon Park Sang Soo Kang Seong Wook Seo Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 International Journal of Ophthalmology ischemia/reperfusion injury hypoxia retinal ganglion cell resveratrol erbb2 |
title | Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 |
title_full | Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 |
title_fullStr | Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 |
title_full_unstemmed | Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 |
title_short | Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2 |
title_sort | resveratrol prevents hypoxia induced retinal ganglion cell death related with erbb2 |
topic | ischemia/reperfusion injury hypoxia retinal ganglion cell resveratrol erbb2 |
url | http://ies.ijo.cn/en_publish/2022/3/20220304.pdf |
work_keys_str_mv | AT hyeminseong resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT jooyeonjeong resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT jinhyunryu resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT juyeongpark resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT yongseophan resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT hyunkyungcho resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT seongjaekim resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT jongmoonpark resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT sangsookang resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 AT seongwookseo resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2 |